Postnatal synapse elimination plays a critical role in sculpting and refining neural connectivity throughout the central and peripheral nervous systems, including the removal of supernumerary axonal inputs from neuromuscular junctions (NMJs). Here, we reveal a novel and important role for myelinating glia in regulating synapse elimination at the mouse NMJ, where loss of a single glial cell protein, the glial isoform of neurofascin (Nfasc155), was sufficient to disrupt postnatal remodeling of synaptic circuitry. Neuromuscular synapses were formed normally in mice lacking Nfasc155, including the establishment of robust neuromuscular synaptic transmission. However, loss of Nfasc155 was sufficient to cause a robust delay in postnatal synapse elimination at the NMJ across all muscle groups examined. Nfasc155 regulated neuronal remodeling independently of its canonical role in forming paranodal axo-glial junctions, as synapse elimination occurred normally in mice lacking the axonalparanodalproteinCaspr.Rather,high-resolutionproteomicscreensrevealedthatlossofNfasc155fromglialcellswassufficienttodisrupt neuronal cytoskeletal organization and trafficking pathways, resulting in reduced levels of neurofilament light (NF-L) protein in distal axons and motor nerve terminals. Mice lacking NF-L recapitulated the delayed synapse elimination phenotype observed in mice lacking Nfasc155, suggesting that glial cells regulate synapse elimination, at least in part, through modulation of the axonal cytoskeleton. Together, our study reveals a glial cell-dependent pathway regulating the sculpting of neuronal connectivity and synaptic circuitry in the peripheral nervous system.
Introduction
Developmental synapse elimination is a critical process in the maturing nervous system, facilitating removal of converging axons and driving the refinement of neural connectivity and synaptic circuitry (Sanes and Lichtman, 1999; Kano and Hashimoto, 2009) . Postnatal synapse elimination at the mouse neuromuscular junction (NMJ) is one of the most intensively studied examples of this fundamental developmental process, but how molecular genetic factors regulate and control the removal of supernumerary axonal inputs from skeletal muscle fibers remains unclear (Sanes and Lichtman, 1999; Kano and Hashimoto, 2009) . Despite a growing awareness of factors intrinsic to motor neuron circuitry that influence the process of synapse elimination at the NMJ, the role that cells other than motor neurons may play in the process is yet to be fully explored. For example, although recent studies have begun to uncover important contributions that glial cells can make to the development and stability of the nervous system in vivo (Ullian et al., 2001; Reddy et al., 2003; Bishop et al., 2004; Fuentes-Medel et al., 2009; Eroglu and Barres, 2010) , their potential contribution to postnatal synapse elimination in the peripheral nervous system remains to be fully established. Moreover, specific glial cell genes and proteins that are required to modulate interactions with neighboring neurons during developmental synapse elimination in the periphery have yet to be identified.
The glial isoform of Neurofascin (Nfasc155) is an abundantly expressed protein in all myelinating Schwann cells (Sherman et al., 2005) . Nfasc155 is predominantly clustered at the paranodal junction in myelinated nerves where it acts as the glial ligand for the axonal Caspr/Contactin complex ( Fig. 1A) (Charles et al., 2002; Poliak and Peles, 2003) . Nfasc155 is required for physical formation of paranodes in the peripheral nervous system (Sherman et al., 2005) . Loss of Nfasc155 expression disrupts axo-glial interactions formed during the critical early postnatal period when myelination and synapse elimination are both occurring in rodents (Sanes and Lichtman, 1999; Poliak and Peles, 2003) . We therefore sought to test the influence of glial cells on postnatal maturation of the nervous system by examining synapse elimination in mice lacking Nfasc155. We show that neuromuscular synapses are formed normally in mice lacking Nfasc155, including the establishment of robust neuromuscular synaptic transmission. However, we report that loss of Nfasc155 is sufficient to cause a robust delay in postnatal synapse elimination at the NMJ, mediated, at least in part, by modulating the distribution of neurofilament light protein (NF-L) in motor neurons.
Materials and Methods
Ethics statement. All animal experiments were approved by a University of Edinburgh internal ethical review panel and were performed under the relevant personal and project licenses from the United Kingdom Home Office (Project License 60/3891).
Mice. Breeding pairs of Cnp-Cre/ϩ Nfasc ϩ/fl X Cnp ϩ/ ϩ Nfasc fl/fl and Caspr ϩ/Ϫ X Caspr ϩ/Ϫ on a C57BL/6 background were established and maintained by the P.J.B. laboratory. Cnp-Cre/ϩ mice (Lappe-Siefke et al., 2003) , Nfascϩ/fl mice (Zonta et al., 2011) , Caspr ϩ/Ϫ mice (Gollan et al., 2003) , and NF-L Ϫ/ Ϫ mice (Zhu et al., 1997) were generated as previously reported. P3-P18 Cnp-Cre Nfasc fl/fl mice were compared with Cnp ϩ/ ϩ Nfasc fl/fl or Cnp ϩ/ ϩ Nfasc ϩ/fl littermate controls. P10 -P12 Caspr Ϫ/ Ϫ mice were compared with Caspr ϩ/ ϩ littermate controls. Breeding pairs of NF-L ϩ/Ϫ X NF-L ϩ/Ϫ on a congenic C57BL/6 background were used to generate litters of NF-L ϩ/ ϩ , NF-L ϩ/Ϫ , and NF-L Ϫ/ Ϫ mice. NF-L Ϫ/ Ϫ mice were compared with NF-L ϩ/ ϩ and NF-L ϩ/Ϫ littermate controls. C57BL/6 litters were obtained from in-house breeding stocks at the University of Edinburgh. Mice were killed by inhalation overdose of isoflurane, intraperitoneal injected overdose of Euthatal, or cervical dislocation, in accordance with the guidance and rules of the United Kingdom Home Office. Both female and male mice were used in this study.
Immunohistochemistry. Levator auris longus (LAL), deep hindlimb lumbrical, tibialis anterior (TA), sternocleidomastoid (SCM), transversus abdominis (TVA) muscles, sciatic/tibial nerve, and lumbar vertebral column were dissected in 0.1 M PBS. Muscles were fixed in 0.1 M PBS 4% PFA (Electron Microscopy Sciences) for 10 min (whole legs for TA were fixed for 1 h) at room temperature. Peripheral nerves were fixed for 30 min at room temperature. Lumbar regions of vertebral column were fixed for 2 h at room temperature. Muscles were processed as whole mount (LAL, lumbricals, TVA, and SCM) or muscle sections (TA). TA muscles were sectioned at 100 m on a freezing microtome. Sciatic/tibial nerves and lumbar spinal cords were sectioned at 10 m on a cryostat. Whole muscles/sections were incubated in 2% Triton X in 0.1 M PBS for 30 min, blocked in a solution of 4% BSA and 1% Triton X in 0.1 M PBS for 30 min before overnight incubation with primary antibodies raised against 200 kDa neurofilament/neurofilament-heavy (NF-H) (rabbit, 1:1000, Abcam), 165 kDa neurofilament/neurofilament-medium (NF-M) (mouse, 1:200, Developmental Studies Hybridoma Bank), 70 kDa neurofilament/NF-L (rabbit, 1:1000, Millipore), and ␤3-tubulin (rabbit, 1:1000, Abcam) in blocking solution. For labeling of paranodes, muscles were incubated in 4% Triton X in 0.1 M PBS for 30 min, blocked in a solution of 4% Triton X and 4% BSA for 30 min before overnight incubation with primary antibody against pan-neurofascin (Nfasc) (rabbit, 1:1000, Abcam) in blocking solution. After 3 ϫ 20 min washes in 0.1 M PBS, muscles were incubated in a solution of swine anti-rabbit secondary antibody conjugated to the fluorescent label FITC (1:40, Dako) and donkey anti-mouse second- ary antibody conjugated to the fluorescent label Cy3 (1:200; Jackson ImmunoResearch Laboratories) in 0.1 M PBS for 2 h. Muscles were exposed to either ␣-bungarotoxin (BTX) conjugated to TRITC (TRITC-␣-BTX; 10 g/ml, Biotium) or ␣-BTX conjugated to CF633 (Far-red-␣-BTX; 10 g/ml, Biotium) for 10 min, washed several times in 0.1 M PBS, whole-mounted in Mowiol (Calbiochem) on glass slides and coverslipped before imaging. Fixed sciatic nerve fibers were teased in 0.1 M PBS on 3-aminopropyltriethoxysilane-coated slides. Teased fibers, sciatic nerve, tibial nerve, and spinal cord sections were incubated in a solution of 0.2% Triton X and 5% BSA for 1 h before overnight incubation in primary antibodies against pan-Nfasc (either rabbit, 1:1000, Abcam or; rabbit, 1:500 dilution, P.J.B. laboratory), Caspr (rabbit, 1:100, P.J.B. laboratory), ankyrin-G (goat, 1:500, Santa Cruz Biotechnology), kinesin 5A (rabbit, 1:200, Abcam), and NF-L (rabbit, 1:1000, Millipore). After 3 ϫ 20 min washes in 0.1 M PBS, nerve teased fibers/sections and spinal cord sections were incubated in a solution of swine anti-rabbit secondary antibody conjugated to the fluorescent label FITC (1:40, Dako), donkey anti-goat secondary antibody conjugated to the fluorescent label Cy3 (1:500, Jackson ImmunoResearch Laboratories), and donkey anti-mouse secondary antibody conjugated to the fluorescent label Cy3 (1:200, Jackson ImmunoResearch Laboratories) for 2 h. After several washes in 0.1 M PBS, sections and teased fibers were coverslipped in Mowiol (Calbiochem) before imaging.
Quantitative Western blots. Western blotting was performed as previously described (Wishart et al., 2012) . Membranes were incubated with primary antibodies against ␤-actin (rabbit, 1:1000 dilution, Abcam), pan-Nfasc (rabbit, 1:1000 dilution, Abcam), NF-H (rabbit, 1:10,000 dilution, Abcam), NF-M (mouse, dilution 1:2000 dilution, Developmental Studies Hybridoma Bank), and NF-L (rabbit, 1:3000 dilution, Millipore).
Microscopy. Muscle, nerve, and spinal cord preparations were viewed using a phase-contrast microscope with a chilled CCD camera (40ϫ objective, for muscle fiber measurements), a standard epifluorescence microscope with a chilled CCD camera (20ϫ and 40ϫ objective, 0.8 NA, Nikon IX71 microscope, Hammamatsu C4742-95; for endplate area, endplate number, and endplate maturation), an upright fluorescence microscope (40ϫ and 60ϫ objective, for polyinnervation and axonal input per NMJ), or a laser scanning confocal microscope (40ϫ and 60ϫ objective, 1.4 NA, Zeiss LSM710; number of axons innervating a muscle, polyinnervation counts, preterminal axon and axon terminal fluorescence intensity, spinal cord ventral root fluorescence intensity, peripheral nerve fluorescence intensity, and axonal input per NMJ). TRITC-labeled preparations were imaged using 543 nm excitation and 590 nm emission optics, and FITC-labeled preparations used 488 nm excitation and 520 nm emission optics. For confocal microscopy, 488, 543, and 633 nm laser lines were used for excitation and confocal Z-series were merged using Zen software. Identical confocal microscope settings were used between groups when imaging sciatic and tibial nerve sections, spinal cord sections, and muscle preparations for fluorescence intensity measurements. Images shown are z-projections. Spinal cord sections for motor neuron cell body counts were imaged using a light microscope with a camera (Leica DMLB, DFC480 camera).
Quantification of immunohistochemically labeled muscles, nerves, and ventral roots. A minimum of 80 endplates in each LAL, 50 endplates in each TA, 80 endplates in each TVA, 100 endplates in each SCM, and 30 endplates in each lumbrical muscle selected at random were assessed with the operator blind to genotype. Only clearly identified, nonoverlapping endplates were analyzed. The number of axons innervating the LAL was quantified by taking a z-stack confocal image of the nerve to create a digital 3D reconstruction. By scanning through the axon bundle along the z-axis, we visualized individual axons in the XY plane in cross section. Individual muscle fiber diameters (Ͼ75 per muscle) were measured in ImageJ from ϫ20 phase-contrast images from teased muscle fiber preparations. Endplate area measurements (Ͼ40 per muscle) were made in ImageJ with outlines manually traced to calculate area. Fluorescence intensity measurements (45-60 preterminal and terminal axons per muscle; 1000 -1500 axons per nerve; 100 -120 axons per ventral root) were performed using ImageJ, by measuring 10 points of intensity along terminal axons labeled for NF-L and NF-M, from branch point to neuromuscular junction; by drawing a box around the axon terminals overlying the endplate labeled for NF-L and NF-M; or by drawing a small box within a transversely sectioned axon in the sciatic/tibial nerve and spinal ventral root to measure the average intensity of kinesin 5A and NF-L. The same size box was used to measure intensity in all axons. In muscles double-immunolabeled for NF-M and NF-L, fluorescence intensity between neurofilaments was matched in the preterminal axons before fluorescence measurements were taken. A ratio of nerve terminal/ preterminal axon fluorescence intensity was then calculated to accurately compare the levels of each neurofilament in axon terminals.
Quantification of spinal cord motor neurons. Spinal cords from P11 mice were dissected, postfixed in 4% PFA for 2 h, cryoprotected in 30% sucrose overnight, and incubated in a 50:50 solution of OCT medium: 30% sucrose before rapidly embedding and freezing on dry ice. The 10-m-thick horizontal sections were cut on a cryostat and stained with 0.5% cresyl violet with 0.04% acetic acid. A minimum of 30 nonadjacent sections from the lumbar region of the spinal cord were examined for large, polygonal, Nissl-positive cells in the ventral horn of the spinal cord anterior to the central canal. Quantification was performed on sections 100 m apart to avoid double counting of neurons. Quantification was performed blinded to the genotype.
Electrophysiology. Electrophysiology of conduction velocity in the sciatic nerve was performed in Nfasc155 Ϫ/ Ϫ , Caspr Ϫ/ Ϫ , and littermate controls at P11 as previously described (Court et al., 2004) . Electrophysiology on nerve-muscle preparations from Nfasc155 Ϫ/ Ϫ and littermate controls ranging from P10-P13 was performed on flexor digitorum brevis muscles as previously described . A minimum of 60 muscle fibers were recorded from per mouse.
Electron microscopy. Sciatic nerves were prepared for electron microscopy and analyzed for G-ratio counts as previously described (Sherman et al., 2012) using ImageJ. A total of 30 -50 fibers were measured per nerve.
Proteomic analysis. Whole sciatic-tibial nerve preparations from Nfasc155 ϩ/ ϩ , Nfasc155 Ϫ/ Ϫ , Caspr ϩ/ ϩ , and Caspr Ϫ/ Ϫ mice (N ϭ 5 per genotype) were pooled into four groups for each genotype, for iTRAQ proteomic analysis. Protein was extracted from tissues in 1 ml of buffer containing 6 M urea, 2 M thiourea, 2% CHAPS, and 0.5% SDS in dH 2 O with 1% proteinase inhibitor (Roche). Tissues were homogenized in M tubes (Miltenyi Biotec) using gentleMACS dissociator machine on M tube protein cycle followed by centrifugation at 300 ϫ g for 2 min at room temperature. Homogenates were left on ice for 15 min before centrifugation at 20,000 ϫ g for 20 min at 4°C. After extraction, protein concentrations of the soluble homogenate fractions were determined via BCA assay and used for downstream proteomic analysis as previously described (Wishart et al., 2010 (Wishart et al., , 2012 (Wishart et al., , 2014 . Raw data files were converted to mascot generic file (mgf) and searched against (IPI Mouse, Version 10/02/2014) through Proteome discoverer (Version 1.4) with the Mascot search engine (Version 2.3.2) database. To obtain further insights into cellular pathways and protein interaction networks modified as a result of the Nfasc155 Ϫ/ Ϫ and Caspr Ϫ/ Ϫ genotypes, Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems) was used. All proteins submitted to IPA software for bioinformatics analyses were identified by Ͼ1 unique peptide and had expression levels either increased or decreased Ͼ20% in Nfasc155 Ϫ/ Ϫ or Caspr Ϫ/ Ϫ mice compared with littermate controls. IPA dynamically generates networks of gene, protein, small molecule, drug, and disease associations on the basis of "handcurated" data held in a proprietary database. Changes in specific protein interaction networks were identified on the basis of the number and percentage of candidate proteins contributing to the entire network.
Statistical analysis. Statistical analyses were performed using GraphPad Prism software. p values Ͻ0.05 were considered to be statistically significant. All bar charts are shown as mean Ϯ SEM. (Yu et al., 1994) and Nfasc is normally expressed postnatally at the onset of myelination (Collinson et al., 1998; Tait et al., 2000) . Nfasc155 is therefore completely absent from myelinating glia in Cnp-Cre Nfasc fl/fl mice and unlikely to be expressed in Schwann cells that have not taken up 1:1 relationships with axons.
Results

Cnp
As expected, peripheral nerves from Nfasc155 Ϫ/ Ϫ mice showed a complete loss of Nfasc155 protein, with retention of the axonal Nfasc186 isoform (Fig. 1D) . Myelin formation and compaction occurred normally (see Fig. 3A -D). Paranodal junctions were lost in Nfasc155 Ϫ/ Ϫ mice, although nodal architecture remained intact (Fig. 1B) . We observed an ϳ50% reduction in nerve conduction velocities in Nfasc155 Ϫ/ Ϫ mice ( Fig. 1E ), consistent with previous findings from other strains of genetically modified mice lacking Nfasc155 (Pillai et al., 2009) .
Nfasc155
Ϫ/ Ϫ mice were virtually indistinguishable from control littermates up until postnatal day 12 (Fig. 1C) , with similar body weights, activity levels, and gross patterns of behavior. However, a notable tremor was detected in Nfasc155 Ϫ/ Ϫ mice from ϳP13 onwards, with premature death due to unknown causes occurring around postnatal day 18 -20.
Loss of glial Nfasc155 is sufficient to delay synapse elimination at the NMJ Neuromuscular connectivity was established normally in the LAL muscle of Nfasc155 Ϫ/ Ϫ mice, with one NMJ formed on each extrafusal skeletal muscle fiber (Fig. 1 F, G) . However, qualitative observations suggested that many NMJs were innervated by more than one motor axon (polyneuronal innervation) in Nfasc155 Ϫ/ Ϫ mice at P11 (Fig. 1G ). By contrast, synapse elimination was almost complete in control littermates at this time point, resulting in the majority of NMJs being innervated by a single motor axon (mononeuronal innervation; the mature innervation state) (Fig. 1F ) .
Quantitative assessment of neuromuscular innervation between P3 and P18 revealed a significant delay in synapse elimination in Nfasc155 Ϫ/ Ϫ mice ( Ϫ/ Ϫ mice were twofold higher than those in controls. Interestingly, the numbers of polyneuronally innervated NMJs were identical in Nfasc155 ϩ/ ϩ and Nfasc155 Ϫ/ Ϫ mice at P3 ( Fig. 2A) , suggesting that the increased number of polyinnervated endplates was the result of a delay in the removal of supernumerary axons in the early postnatal period rather than as a result of prenatal hyperinnervation of NMJs.
We could not detect Nfasc155 expression in terminal Schwann cells from wild-type mice (in contrast to the clear staining associated with myelinating Schwann cells observed at paranodes) (Fig. 3G) . Thus, although terminal Schwann cells are thought to influence the outcome of synapse elimination at the NMJ (Keller-Peck et al., 2001a; Darabid et al., 2013) , disruption of Nfasc155 in this specific cell type was unlikely to be a major cause of delayed elimination in Nfasc155 Ϫ/ Ϫ mice. Interestingly, pan-Nfasc labeling of P9 control muscle also revealed an absence of paranodes from preterminal axons entering the NMJ (Fig. 3G ). This is in agreement with previous studies demonstrating that preterminal axons are only myelinated after the process of synapse elimination is complete (Bixby, 1981; Slater, 1982) , thereby eliminating paranodal development in preterminal axons as a determining factor in the outcome of synapse elimination in Nfasc155 Ϫ/ Ϫ mice. ϩ/ ϩ and Nfasc155 Ϫ/ Ϫ mice. There was a significant difference in the percentage of ovoid plaques ( p ϭ 0.0022; Mann-Whitney U test; N ϭ 3 mice per genotype, two muscles analyzed per mouse), perforated endplates ( p ϭ 0.0022), and branched endplates ( p ϭ 0.0022), revealing a significant delay in endplate maturation in Nfasc155 Ϫ/ Ϫ mice (60 -160 endplates measured per muscle). Data are mean Ϯ SEM. **p Ͻ 0.01. J, Example confocal micrographs of P15 ovoid plaque (immature), perforated (developing), and branched (mature) endplates. Scale bar, 10 m.
To confirm that delayed elimination observed in Nfasc155 Ϫ/ Ϫ mice was not the result of the presence of Cre or lox P sites, we quantified levels of polyinnervation in both Cnp-Cre and Nfasc fl/fl mice. Increased levels of polyinnervation were only seen in mice that were positive for both Cre and Nfasc fl/fl with normal levels seen in Cnp-Cre and Nfasc fl/fl mice (Fig. 3H ) . Thus, loss of one single glial cell gene/protein (Nfasc155) was sufficient to delay the process of synapse elimination at the NMJ, leading to disrupted remodeling of synaptic circuitry.
Postsynaptic motor endplate maturation is similarly delayed in Nfasc155
؊/؊ mice Presynaptic and postsynaptic maturation is tightly correlated at the mammalian NMJ (Balice- Gordon and Lichtman, 1993; Lichtman and Colman, 2000) . We therefore wanted to establish whether delayed maturation of presynaptic axonal inputs in Nfasc155 Ϫ/ Ϫ mice was accompanied by a comparable delay in motor endplate maturation. Motor endplate morphology was quantified in Nfasc155 Ϫ/ Ϫ mice and controls at P15 (Fig. 3 I, J ). Postsynaptic motor endplate maturation was significantly delayed in Nfasc155 Ϫ/ Ϫ mice (Fig. 3I ) , as indicated by the higher number of motor endplates with an immature morphological appearance. This finding confirms that developmental synapse elimination was robustly delayed in Nfasc155 Ϫ/ Ϫ mice, influencing maturation of both presynaptic and postsynaptic aspects of the NMJ.
Neuromuscular transmission is normal in Nfasc155
؊/؊ mice Flexor digitorum brevis muscles from Nfasc155 ϩ/ ϩ and Nfasc155 Ϫ/ Ϫ mice exhibited sustained tetanic contractions in response to supramaximal nerve stimulation (data not shown). Individual muscle fibers showed evidence for miniature endplate potentials and responded to tibial nerve stimulation with action potentials (Fig. 3 E, F ) . Mean endplate potential latency was significantly prolonged in Nfasc155 Ϫ/ Ϫ mice (3.50 Ϯ 0.45 ms, N ϭ 4, two muscles per mouse), versus Nfasc155 ϩ/ ϩ mice (2.73 Ϯ 0.14 ms, N ϭ 11, 19 muscles in total; p ϭ 0.022; unpaired onetailed t test), but peak endplate potential amplitudes were similar in both genotypes (ϳ12 mV; p Ͻ 0.05). Interestingly, there was also greater variability of evoked response latency in the data from the same two groups of mice (F ϭ 3.96; df ϭ 7/19; p ϭ 0.016). Thus, taking the tension observations together with the electrophysiological recording data, it would appear that delayed synapse elimination in Nfasc155 Ϫ/ Ϫ mice cannot be explained by differences in activity underpinned by any fundamental or systematic weakness or fatigability of neuromuscular transmission because NMJs were physiologically competent to generate sustained muscle force. This was evident despite measurable deficiencies in nerve conduction, as indicated by more variable and prolonged evoked response latencies.
Global delay in synapse elimination across a range of skeletal muscles with varying developmental subtypes and locations in Nfasc155
؊/؊ mice To establish whether delayed synapse elimination initially identified in the LAL muscle was recapitulated across a range of different skeletal muscles from throughout the body, we extended our analyses to incorporate muscles with varying anatomical locations and developmental subtypes. Similar delays in synapse elimination were observed in the deep lumbrical muscles from the hindpaw of Nfasc155 Ϫ/ Ϫ mice, as well as in both distinct muscle bands of the LAL, containing NMJs with both fastsynapsing and delayed-synapsing developmental phenotypes (Fig. 4A-F ) (Pun et al., 2002; . Increased levels of polyinnervation were also observed in the SCM, TVA, and TA muscles from Nfasc155 Ϫ/ Ϫ mice at P12 (Fig. 4G-I ). Thus, a profound delay in synapse elimination was observed in all muscle groups examined, with no apparent influence from either developmental subtypes or anatomical location.
Motor neuron pools, numbers of innervating axons, muscle fiber diameters, motor endplate areas and NMJ number are all unchanged in Nfasc155 ؊/؊ mice It remained possible that the increased levels of polyneuronal innervation we observed in Nfasc155 Ϫ/ Ϫ mice were occurring because of differences in other aspects of neuromuscular development and maturation (e.g., numbers of motor neurons/motor axons innervating a given muscle, differences in the size of skeletal muscle fibers, and/or the number of motor endplates per muscle), rather than due to a direct delay in the removal of supernumerary axon branches. To test this possibility, we examined a range of other morphological parameters of the neuromuscular system in Nfasc155 Ϫ/ Ϫ mice (Table 1) . We found no differences in either the number of motor neuron cell soma in the spinal cord or the number of axons innervating each muscle in Nfasc155 Ϫ/ Ϫ mice (Table 1) . Similarly, there was no change in muscle fiber diameter, endplate area, or endplate number (Table 1 ). In addition, delayed synapse elimination in Nfasc155 Ϫ/ Ϫ mice did not appear to be caused by a systemic maturational delay in the animals. For example, at P11, when polyinnervation levels were twofold increased in the Nfasc155 Ϫ/ Ϫ mice, there was no difference in body weight, motor development (e.g., ability to self-right), or gross behavioral characteristics compared with Nfasc155 ϩ/ ϩ controls (Fig. 1C) .
Synapse elimination occurs normally in Caspr
؊/؊ mice To address whether delayed synapse elimination observed in Nfasc155 Ϫ/ Ϫ mice was occurring as a direct result of the loss of physical axo-glial interactions at paranodal junctions, we next assessed synapse elimination in mice lacking Caspr, the axonal protein required for paranodal axo-glial interactions (Fig. 1A ) (Bhat et al., 2001; Feinberg et al., 2010) . The underlying rationale of these experiments was that, if synapse elimination were being delayed in Nfasc155 Ϫ/ Ϫ mice as a consequence of disrupted paranode formation or stability, a similar delay in elimination should be observed in Caspr Ϫ/ Ϫ mice. As expected, Caspr Ϫ/ Ϫ mice had disrupted paranodes (Fig. 5A) . However, in stark contrast, P10 Caspr Ϫ/ Ϫ mice showed no difference in levels of polyneuronal innervation compared with littermate controls (Fig. 5 B, C) . Although Nfasc155 was not localized to paranodes of Caspr Ϫ/ Ϫ mice, these mice still expressed high levels (Ͼ70%) of Nfasc155 in the spinal cord (Fig. 5E ) and peripheral nerve (Fig. 5F ), suggesting that Nfasc155 expression was not significantly diminished in glial cells. Thus, delayed synapse elimination in Nfasc155 Ϫ/ Ϫ mice was not caused by disruption to Nfasc155's canonical role in regulating physical axo-glial interactions at the paranode.
Delayed synapse elimination in Nfasc155
؊/؊ mice is not caused by a reduced conduction velocity Next, we wanted to establish whether delayed synapse elimination observed in Nfasc155 Ϫ/ Ϫ mice was the result of the reduced nerve conduction velocities previously observed (Fig. 1E) . A parallel analysis of nerve conduction velocities in Caspr Ϫ/ Ϫ mice revealed an almost identical ϳ50% reduction (Fig. 5D) , consistent with previous findings on mice lacking Caspr and CCR10 (Bhat et al., 2001 ). Thus, the delay in synapse elimination observed in Nfasc155 Ϫ/ Ϫ mice was not the result of perturbations in the conductive properties of peripheral nerve, as a similar reduction in conduction velocity in Caspr Ϫ/ Ϫ mice did not affect the rate of synapse elimination.
Loss of Nfasc155 from glial cells is sufficient to cause targeted disruption of neuronal cytoskeletal organization and trafficking pathways
The finding that loss of Nfasc155 led to a robust delay in synapse elimination, whereas synapse elimination occurred normally in Caspr Ϫ/ Ϫ mice, led us to propose that Nfasc155 was regulating synapse elimination by a mechanism independent of its canonical role in generating physical interactions with the axon at the paranode. It is known that exogenous application of either the extracellular domain of Nfasc155 or anti-Neurofascin antibodies does not modulate neuronal stability or induce axonal retraction in vitro (Charles et al., 2002) . Thus, it was unlikely that Nfasc155 was modulating synapse elimination in neighboring motor axons by acting as a secreted/soluble factor.
To better understand the molecular pathways through which glial Nfasc155 was regulating remodeling of neighboring neurons, independent of its paranodal functions, we undertook a four-way comparative proteomic iTRAQ analysis of sciatic-tibial nerve using tissue harvested from Nfasc155 Ϫ/ Ϫ and Caspr Ϫ/ Ϫ mice at P12, alongside littermate controls from both lines (see Materials and Methods). To generate a list of proteins with modified expression levels in sciatic-tibial nerves from Nfasc155 Ϫ/ Ϫ and Caspr Ϫ/ Ϫ mice, where we could be confident of the identification and measurement of individual proteins, we filtered all raw proteomics data using an established protocol (Wishart et al., 2014) : only proteins identified by Ն2 unique peptides and modified Ͼ20% or Ͻ20% compared with littermate controls were used for further analysis. A total of 1210 proteins had modified levels in peripheral nerve from Nfasc155 Ϫ/ Ϫ mice compared with their littermate controls, whereas only 405 proteins showed modified expression levels in Caspr Ϫ/ Ϫ mice compared with their littermate controls (Fig. 6A) . Interestingly, of the 405 proteins found to have modified levels in Caspr Ϫ/ Ϫ mice, 56 were similarly changed in Nfasc155 Ϫ/ Ϫ mice (Fig. 6B) . Given that both strains of mice had disrupted paranodes, but only Nfasc155 Ϫ/ Ϫ mice had delayed synapse elimination, we subtracted these 56 proteins from those modified in Nfasc155 Ϫ/ Ϫ mice to leave us with a dataset of proteins whose expression changes directly correlated with delayed synapse elimination (1154 proteins distinctly changed in Nfasc155 Ϫ/ Ϫ mice; Fig. 6B ). To better understand the functional consequences of proteome disruption in peripheral nerve of Nfasc155 Ϫ/ Ϫ mice, we used bioinformatics-based IPA pathway analysis software (see Materials and Methods) to identify functional clustering of the 1154 modified proteins into targeted biological networks. IPA analyses revealed significant clustering of proteins into cellular and molecular functions surrounding "cellular assembly and organization" (Table 2) , with 299 of the 1154 distinctly changed proteins identified in Nfasc155 Ϫ/ Ϫ mice belonging to these functions. Closer analysis of this functional cluster revealed widespread disruption to molecular pathways and processes implicated in cytoskeletal organization and trafficking, including subsets of proteins with increased levels as well as subsets of proteins with decreased levels (Table 3 ). All of these 299 proteins were either unchanged in Caspr Ϫ/ Ϫ mice or revealed changes occurring in the opposite direction to Nfasc155 Ϫ/ Ϫ mice. Kinesin, dynein, and dynactin are essential motor proteins for cytoskeletal organization and trafficking, known to play important roles in regulating anterograde and retrograde transport of intermediate filaments throughout the entire length of neuronal axons (Shah et al., 2000; Shea and Flanagan, 2001; Xia et al., 2003; Motil et al., 2006; Uchida et al., 2009; Lee et al., 2011) . Levels of all three of these motor proteins, including several distinct isoforms, were found to be significantly modified in Nfasc155 Ϫ/ Ϫ mice (Table 4) . Importantly, 8 of these 10 proteins remained unchanged in Caspr Ϫ/ Ϫ mice (Table 4) , and the two proteins that were also changed in Caspr Ϫ/ Ϫ mice showed increased protein levels, where levels were decreased in Nfasc155 Ϫ/ Ϫ mice. Thus, reduced levels of core transport proteins in peripheral nerve correlated with delayed synapse elimination in Nfasc155 Ϫ/ Ϫ mice. Our proteomic analysis was performed on whole sciatic-tibial nerve preparations, incorporating a large number of myelinating Schwann cells as well as neuronal axons. Glial cells are known to express isoforms of transport proteins, including kinesin light chain (Kamal et al., 2001 ) and kinesin heavy chain (Schmidt et al., 2012) . To validate the changes in cytoskeletal transport and organization proteins identified in our proteomic screen and to confirm that these changes were occurring in axonal processes of neurons, we immunolabeled sciatic nerve sections from Nfasc155 Ϫ/ Ϫ mice and littermate controls for kinesin 5A, which is predominantly expressed in axons (Xia et al., 1998) and was found to be downregulated in Nfasc155 Ϫ/ Ϫ mice. This analysis confirmed a statistically significant reduction in levels of kinesin 5A in axons from Nfasc155 Ϫ/ Ϫ mice compared with littermate controls (Fig. 6C,D) .
Selective reduction in levels of NF-L in distal motor axons from Nfasc155
؊/؊ mice As previously mentioned, kinesin, dynein, and dynactin are essential for anterograde and retrograde transport of intermediate filaments throughout the entire length of neuronal axons (Shah et al., 2000; Shea and Flanagan, 2001; Xia et al., 2003; Motil et al., 2006; Uchida et al., 2009; Lee et al., 2011) . We therefore hypothesized that, if networks of cytoskeletal transport proteins were disrupted in Nfasc155 Ϫ/ Ϫ mice, corresponding changes in the composition and/or subcellular arrangement of the neurofilament cytoskeleton may also be present in peripheral nerve. Importantly, neurofilament dynamics have previously been proposed to influence synapse elimination (Donahue et al., 1988; Roden et al., 1991) , and a recent study from Monsma et al. (2014) has revealed that myelinating glial cells can regulate the neurofilament content and organization of axons via local modulation of transport pathways.
To address this possibility, we examined levels of NF-H, NF-M, and NF-L proteins in the distal portions of motor axons in LAL preterminal axons from P11 Nfasc155 Ϫ/ Ϫ and Caspr
mice. Similar levels of NF-M and NF-H were present in Nfasc155 Ϫ/ Ϫ mice, Caspr Ϫ/ Ϫ mice, and their littermate controls (Fig. 7 A, B) . This is consistent with our finding that axon caliber was unaffected in peripheral nerve of Nfasc155 Ϫ/ Ϫ mice (Fig.  3C) , as changes in NF-M and NF-H would be expected to influence the radial growth of axons (de Waegh et al., 1992; Sánchez et al., 2000) . However, motor axons, their terminal collateral branches, and axon terminals had significantly lower levels of NF-L in Nfasc155 Ϫ/ Ϫ mice compared with controls (Fig. 7C,D) . In contrast, NF-L levels remained unchanged in Caspr Ϫ/ Ϫ mice (Fig. 7C,D) . Thus, reduced levels of NF-L in motor nerve terminals correlated with defects in synapse elimination.
To determine whether this selective reduction in NF-L from distal axons was contributing directly to the delay in synapse elimination observed in Nfasc155 Ϫ/ Ϫ mice, we examined the rate of synapse elimination in mice lacking NF-L (Zhu et al., 1997) . The absence of NF-L from motor axons in NF-L Ϫ/ Ϫ mice was confirmed using immunohistochemistry (Fig. 7F ) . Synapse elimination was significantly delayed in the TA muscle of NF-L Ϫ/ Ϫ mice, with almost twice as many polyinnervated motor endplates in NF-L Ϫ/ Ϫ mice at P11 compared with control mice (NF-L (Fig. 7 E, G) . Interestingly, however, the magnitude of the delay in synapse elimination observed in NF-L Ϫ/ Ϫ mice was less than that previously observed in Nfasc155 Ϫ/ Ϫ mice (increase of 79% in NF-L Ϫ/ Ϫ mice vs increase of 198% in Nfasc155 Ϫ/ Ϫ mice). This suggests that NF-L-dependent pathways can only account for part of the mechanism through which Nfasc155 regulates synapse elimination but does confirm that loss glial cell control of synapse elimination is likely to be mediated, at least in part, through modulation of the axonal cytoskeleton.
Altered subcellular distribution of NF-L in motor neurons from Nfasc155
؊/؊ mice Our finding that defective expression of key axon transport proteins correlated with a selective reduction in NF-L levels at motor The number of changed proteins, identified in the Nfasc155 Ϫ/Ϫ mice, previously shown to be involved in each pathway and process is also shown, along with the direction of change. nerve terminals from Nfasc155 Ϫ/ Ϫ mice suggested that loss of Nfasc155 was likely to be modulating neurofilament dynamics by influencing the subcellular distribution of neurofilament proteins, rather than by regulating overall NF-L levels. This model was supported by proteomic data showing that NF-L levels were not reduced in whole sciatic-tibial nerve preparations from Nfasc155 Ϫ/ Ϫ mice. To establish whether loss of Nfasc155 was mediating NF-L levels by modulating subcellular distribution, we measured NF-L levels in axons from distal tibial nerve and motor ventral roots exiting the spinal cord. Transversely sectioned tibial nerve from P14 Nfasc155 Ϫ/ Ϫ and Nfasc155 ϩ/ ϩ mice immunolabeled for NF-L revealed significantly lower levels in Nfasc155 Ϫ/ Ϫ mice (Fig. 8C,D) , corresponding to the reduced NF-L levels observed in motor nerve terminals. In contrast, NF-L levels in ventral roots from the same animals revealed significantly higher levels in Nfasc155 Ϫ/ Ϫ mice ( Fig.  8 A, B) . Thus, NF-L was accumulating in proximal regions of the motor neuron from Nfasc155 Ϫ/ Ϫ mice at the same time as being depleted from distal regions (Fig.  8E ), indicating that Nfasc155 was modulating NF-L dynamics in motor neurons by regulating its trafficking and subsequent subcellular distribution.
NF-L is present in axon terminal
protrusions at the NMJ Finally, we wanted to address why NF-L in particular (rather than NF-M or NF-H) appeared to be playing a key role in regulating synapse elimination at the NMJ. Several recent studies have highlighted the important role that dynamic axon terminal protrusions play in competing for territory at the NMJ and remodeling nerve terminals during synapse elimination (Keller-Peck et al., 2001a; Walsh and Lichtman, 2003; Turney and Lichtman, 2012) . Given that NF-L (rather than NF-M or NF-H) has been shown to be critical for the dynamic growth and stability of motor neuron dendrites in vivo and neurite processes in vitro Chen et al., 2014) , we hypothesized that NF-L may be selectively associated with dynamic axon terminal protrusions at the NMJ.
LAL muscles from C57BL/6 mice at P10 were immunolabeled for NF-L and NF-M to allow direct comparison of their nerve terminal distribution patterns at individual NMJs. NF-L levels were consistently higher than corresponding NF-M levels in motor nerve terminals overlying the endplate when intensities of NF-M and NF-L were identical in preterminal axons (Fig. 9A-C) . Importantly, NF-L was commonly observed at high levels in fine axon terminal protrusions, often extending beyond the boundary of the postsynaptic motor endplate, where NF-M was almost entirely absent (observed at 16% of endplates; 42 of 269 NMJs across four mice) (Fig. 9 A, B) . Thus, NF-L was present in terminal protrusions associated with dynamic remodeling of motor nerve terminals (Keller-Peck et al., 2001a; Walsh and Lichtman, 2003; Turney and Lichtman, 2012) , making it ideally placed to mediate cytoskeletal adaptations required for retraction and elimination of supernumerary inputs during synapse elimination. We therefore suggest that loss of NF-L from axon terminals in Nfasc155 Ϫ/Ϫ mice results in reduced dynamic remodeling, which is essential for synapse elimination to proceed at normal rates.
Discussion
In this study, we reveal a novel and important role for myelinating glia in regulating synapse elimination at the mouse NMJ. We have identified a single glial cell gene, the glial isoform of neuro- fascin (Nfasc155) that is required for normal postnatal remodeling of synaptic circuitry in the peripheral nervous system. Loss of Nfasc155 was sufficient to cause a robust delay in postnatal synapse elimination at the NMJ across a wide range of different muscle groups and motor neuron subtypes. We demonstrated that Nfasc155 regulated neuronal remodeling independently of its canonical role in forming paranodal axo-glial junctions, as synapse elimination occurred normally in mice lacking the axonal paranodal protein Caspr. Proteomic screens revealed disruption of neuronal cytoskeletal organization and trafficking pathways in peripheral axons from mice lacking glial Nfasc155, correlating with a selective depletion of NF-L protein from distal axons and motor nerve terminals but accumulation in proximal ventral roots of motor neurons. Mice lacking NF-L also had a delayed synapse elimination phenotype, suggesting that glial cells regulate synapse elimination in the periphery, at least in part, through modulation of the axonal cytoskeleton. These findings add significant experimental support to a growing body of evidence revealing critical roles for glial cells in developmental sculpting of the nervous system (Ullian et al. Importantly, the magnitude of delay in synapse elimination that we observed in Nfasc155 Ϫ/ Ϫ mice was what might be expected when modulating (but not entirely blocking) a dynamic developmental process, and was similar to that previously reported in other studies where modulation of leukemia inhibitory factor (Kwon et al., 1995) or gap junction proteins (Personius et al., 2007) have been found to influence the rate of developmental synapse elimination. This is in contrast to other reported experimental manipulations (e.g., overexpression of GDNF) (Nguyen et al., 1998; Keller-Peck et al., 2001b) where delayed synapse elimination was a secondary consequence of increased axonal branching (i.e., generating a larger initial number of synaptic inputs that required subsequent pruning) rather than delayed synapse elimination. Nfasc155 Ϫ/ Ϫ mice may therefore provide an ideal model for use in future studies of the cellular and molecular regulation of synapse elimination in vivo.
The difference between synapse elimination phenotypes we observed in Nfasc155 Ϫ/ Ϫ mice and Caspr Ϫ/ Ϫ mice strongly suggested that glial Nfasc155 influences synapse elimination independently of its canonical role in paranode formation and stabilization (Charles et al., 2002; Poliak and Peles, 2003; Sherman et al., 2005 (Song et al., 2008; Eroglu and Barres, 2010; Smith et al., 2013) , with a more recent study also suggesting a more active role for lysosomal activity within TSCs (Smith et al., 2013) . Here, however, we suggest that myelinating glial cells are playing an active role in dynamic mediation of the synapse elimination process in the peripheral nervous system, mediated at least in part through targeted regulation of cytoskeletal transport and organization pathways in neighboring neurons, with consequences for subcellular localization of NF-L.
It has previously been demonstrated that myelinating Schwann cells can locally modulate the axonal cytoskeleton. For example, a recent study used glial cellneuron cocultures to demonstrate that myelinating glial cells can directly alter transport rates of neurofilaments in neighboring axons (Monsma et al., 2014) , where neurofilaments were transported at a slower rate in myelinated segments of axons compared with unmyelinated segments. Monsma et al. (2014) proposed that a signal must exist, emanating from the myelinating cell to the axon, to impact on cytoskeletal transport dynamics. Our study suggests that Nfasc155-dependent pathways are an excellent candidate for such a signal. Although such signaling processes emanate from myelinating glial cells, our Nfasc155 data show that it is likely to occur independent of the myelination process per se, as myelin formation and deposition occur normally in Nfasc155 Ϫ/ Ϫ mice (Fig. 3A-D) .
The finding that NF-L levels were selectively reduced in distal peripheral nerve axons and motor nerve terminals in Nfasc155 Ϫ/ Ϫ mice provides evidence for at least one direct consequence of disruption to cytoskeletal transport and organization pathways in neurons when Nfasc155 was absent. However, it was initially surprising to us that levels of NF-H and NF-M remained unchanged in Nfasc155 Ϫ/ Ϫ mice. NF-L is the most abundant neurofilament subunit and one of the earliest expressed (Willard and Simon, 1983; Carden et al., 1987) , forming homodimers (Geisler and Weber, 1981; Liem and Hutchison, 1982) as well as interacting with NF-H and NF-M to form intermediate filaments (Leung and Liem, 1996) . Thus, one parsimonious explanation for the apparent selective disruption of NF-L levels in motor nerve terminals of Nfasc155 Ϫ/ Ϫ mice is that perturbations in cytoskeletal transport pathways had the most overt effects on the NF subunit (NF-L) that was most abundant and was required at the earliest stages of cytoskeletal development and maturation. Our finding from knock-out mice experiments that loss of NF-L was sufficient to delay the process of synapse elimination confirms that NF-L is an important NF subunit for the elimination of excess inputs during neuronal development. In addition, our proteomic screen also revealed significant changes in levels of ␣-internexin (upregulated 25%) and peripherin (downregulated 40%) in Nfasc155 Ϫ/ Ϫ mice, two intermediate filament proteins expressed earlier than or at the same time as NF-L in the nervous system (Portier et al., 1983; Escurat et al., 1990; Kaplan et al., 1990) . Thus, it appears that disruption to cytoskeletal transport systems in axons of Nfasc155 Ϫ/ Ϫ mice has the most notable effects on filamentous proteins present during the early stages of nervous system development and maturation.
Our finding that NF-L is selectively localized in fine axon terminal protrusions associated with dynamic remodeling events suggests that NF-L is ideally placed to mediate synapse elimination by influencing cytoskeletal plasticity in regions of motor nerve terminals undergoing remodeling. This suggestion is consistent with previous studies demonstrating a role for NF-L in the growth and stability (Chen et al., 2014) of motor neurons and provides a plausible explanation for why reduced levels of NF-L in Nfasc155 Ϫ/ Ϫ mice lead, at least in part, to a delay in synapse elimination.
Together, our findings highlight a novel and important role for glial cells in the regulation of neuronal remodeling and refinement of synaptic circuitry in the peripheral nervous system, with glial Nfasc155 identified as a critical mediator of this process. The results presented in this study therefore support the view that synapse elimination is not a process controlled entirely by intrinsic properties of neurons but rather is subject to non-cellautonomous regulation by neighboring cells, including glia. Our identification of Nfasc155 as a key glial cell protein capable of mediating neuronal remodeling during developmental synapse elimination, acting at least in part through its ability to influence cytoskeleton dynamics in neurons, provides the basis from which to further explore glial-based control of synaptic circuitry.
